|
Clinical features
|
All patients (n = 1170) number (%) median (max–min)
|
Mortality risk factors OR (CI 95%)
|
Orotracheal intubation risk factor OR (CI 95%)
|
|---|
|
Gender
|
|
Man
|
618 (52.8%)
|
1.078 (0.608–1.91)
|
0.669 (0.43–1.03)
|
|
Woman
|
552 (47.2%)
| | |
|
Age, years
|
51.8 ± 18.4
|
1.14 (1.11–1.17)
|
1.05 (1.04–1.07)
|
|
Age class
|
|
< 29
|
87 (7.4%)
| | |
|
29–59
|
713 (60.9%)
| | |
|
≥ 60
|
370 (31.6%)
|
119.11 (16.37–54.3)*
|
9.24 (2.22–38.51)*
|
|
Clinical outcome
|
|
Mortality
|
49 (4.2%)
|
–
|
–
|
|
Mortality by age class
|
|
< 29
|
0 (0%)
|
–
|
–
|
|
29–59
|
1 (0.1%)
|
–
|
–
|
|
≥ 60
|
48 (13%)
|
–
|
–
|
|
Comorbidities
|
|
Diabetes (type I or II)
|
188 (16.1%)
|
3.57 (1.96–6.48)
|
6.08 (3.9–9.47)
|
|
Obesity
|
122 (10.4%)
|
0.97 (0.38–2.51)
|
2.03 (1.15–3.56)
|
|
Cardiopathy
|
112 (9.66%)
|
6.34 (3.42–11.77)
|
3.14 (1.84–5.34)
|
|
Hypertension
|
368 (31.5%)
|
5.92 (3.14–11.14)
|
4.00 (2.59–6.2)
|
|
COPD/pneumonia
|
62 (5.3%)
|
6.95 (3.41–14.33)
|
2.68 (1.34–5.34)
|
|
Smoking/former smoking
|
43 (3.6%)
|
2.46 (0.85–7.2)
|
1.16 (0.41–3.33)
|
|
Neurological disease
|
70 (6.05%)
|
7.6 (2.072–24.93)
|
3.14 (1.67–5.88)
|
|
CKD
|
28 (2.4%)
|
8.73 (3.52–21.67)
|
8.13 (3.69–17.93)
|
|
Thyroid disease
|
111 (9.5%)
|
1,63 (0.71–3.72)
|
2.23 (1.06–4.71)
|
|
Dyslipidemia
|
171 (14.6%)
|
3.02 (1.64–5.62)
|
1.59 (0.85–2.97)
|
|
Neoplasia/immuno
|
57 (4.9%)
|
2.34 (0.89–6.14)
|
2.83 (1.76–4.57)
|
|
Asthma
|
51 (4.4%)
|
0.45 (0.06–3.3)
|
3.18 (0.43–23.3)
|
|
In-hospital clinical characteristics
|
|
NEWS/PEWS
|
1 (0–13.2)
|
1.5 (1.36–1.63)
|
1.38 (1.28–1.48)
|
|
Time of stay in ICU
|
0 (0–107)
|
1.082 (1.058–1.11)
|
1.42 (1.34–1.5)
|
|
Time of stay in nursery
|
5.0 (0–61)
|
0.95 (0.88–1.02)
|
1.09 (1.06–1.12)
|
|
Time of hospitalization
|
6.0 (1–112)
|
1.047 (1.03–1.06)
|
1.18 (1.15–1.21)
|
|
Time of MV
|
0 (0–66)
|
1.16 (1.12–1.21)
|
NS
|
|
Orotracheal intubation
|
94 (8%)
|
35.2 (18.42–67.65)
|
–
|
|
Prisma
|
24 (2.4%)
|
44.162 (19.36–100.74)
|
NS
|
|
Prona
|
18 (1.5%)
|
6.93 (2.19–21.88)
|
233.8 (30.7–1280.23)
|
|
Vasoactive drugs
|
72 (6.2%)
|
32.15 (16.93–61.044)
|
690.46 (234.27–2034.92)
|
|
CLHO/HCQ
|
76 (6.5%)
|
1.11 (1.03–1.21)
|
22.83 (5.2–100.17)
|
- NS, not significant, Neoplasia/immune, neoplasia/immunosuppression; Time of MV, Time of mechanical ventilation; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; NEWS/PEWS, National Early Warning Score/Pediatric Early Warning Score; Prisma, prisma hemodialysis machine; Prona, prone position; CLHO/HCQ, Chloroquine/hydroxychloroquine; *compared with 29–59 group. Bold: p < 0.05
